openPR Logo
Press release

Upcoming Conference on High Potent Medicines - US Edition | MarketsandMarkets | 18th - 19th April 2024 | Boston, USA

02-06-2024 02:12 PM CET | Health & Medicine

Press release from: ReportsnReports

Upcoming Conference on High Potent Medicines - US Edition |

Looking and the current market scenario, many companies are outsourcing the manufacture of their highly potent compounds for various reasons, mainly marketing. The escalation in the High Potent drug market is subjected to a variety of aspects such as the diversification of pharmaceutical manufacturers towards precision medicines such as HPAPI, increasing demand for oncology drugs & antibody-drug conjugates, and advancements in HPAPI manufacturing technologies.

Enquire Now @ https://events.marketsandmarkets.com/high-potent-medicines-conference-usa/

We are delighted to announce our MarketsandMarkets High Potent Medicines Conference, scheduled to be on 18th - 19th April 2024, in Boston, USA. This conference will evidence the presence of some great minds in the Medical and Pharmaceutical industry bringing you the solutions to the challenges faced in advanced High Potent Medicines. Grab the opportunity to interact with them, 10+ hours of dedicated networking for two days in a row and meet your potential targets to create target revenue.

Register Now @ https://events.marketsandmarkets.com/high-potent-medicines-conference-usa/register

Key Highlights:
• Clarifying the Challenges when Demonstrating the Sterility of a Manufacturing Suite

• Validating Optimal Practices for Primary Containment Measures, Considering Modality for Achieving Quality, Practicality, and Cost-Effectiveness.

• Containment and Handling Strategies

• Inherent risks Linked to the Utilization of Isolators for Hazardous Materials, their impact on operators' safety and product quality.

• Validation of cleaning procedures to avoid cross contamination.

• Assessing process-specific methods to determine the API's hazard level.

Why Should Attend?
From pharmaceutical and Biopharmaceutical manufacturing:
Chief executives, VP's, Directors, Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, Toxicologists, Fellows, Investigators working in:

-Research & Development
-Manufacturing/Operations/Production
-Maintenance
-Engineering
-Risk Assessments
-Laboratory Services/Analytical
-New Technologies
-Process Development/Technical transfer

Become a Speaker @ https://events.marketsandmarkets.com/high-potent-medicines-conference-usa/speaker-enquiry

ADDRESS:
Magarpatta City, Hadapsar, Pune, India - 411013

About Us:-
MarketsandMarkets Conferences, a leading international event organizer since 2014, takes pride in organizing over 200 conferences globally. With our extensive experience and rich legacy, we bring together experts from around the world to drive knowledge sharing and innovation in the healthcare and lifesciences sectors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Upcoming Conference on High Potent Medicines - US Edition | MarketsandMarkets | 18th - 19th April 2024 | Boston, USA here

News-ID: 3374460 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Potent

Key Sessions during the Highly Potent Active Pharmaceutical Conference Released
SMi's 6th Annual Highly Potent APi Conference will also explore the ADC industry, legal aspects, environmental policy, and how to effectively establish a business case for containment - as well as taking a look to the future of HPAPI as new modalities continue to surface. Taking place on 9th - 10th May 2022 in London, UK; the conference will focus on a robust scientific approach to handling HPAPI, from hazard identification
Highly Potent Active Pharmaceutical Ingredients Market 2021 | Detailed Report
ReportsnReports publishes the report titled Highly Potent Active Pharmaceutical Ingredients that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital
Highly Potent API Market Size, Share, Development by 2025
Market Research Report Store offers a latest published report on Highly Potent API Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Highly Potent API players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Highly Potent API with respect
Highly Potent API Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on Highly Potent API Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Highly Potent API market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.
Highly Potent API Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Highly Potent API Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Highly Potent API players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Highly Potent API with respect
Highly Potent APIs 2019 Conference: Interview with Bayer Pharma
Dr Ulrich Rüemenapp, Head of Launch Preparation and Coordination at Bayer Pharma, will be discussing late stage CMC development and bio-manufacturing for fast track projects at SMi’s 3rd annual Highly Potent Active Pharmaceutical Ingredients conference. Ahead of the conference next month, SMi interviewed him where he gave his thoughts on how the industry has progressed and what the future holds for the industry. Ulrich said: “From my point of view the hype